Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C23H48NO7P
CAS Number:
Molecular Weight:
481.60
MDL number:
UNSPSC Code:
51191904
NACRES:
NA.25
Product Name
15:0 Lyso PC, 1-pentadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine, powder
assay
>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)
form
powder
packaging
pkg of 1 × 25 mg (855576P-25mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 855576P
shipped in
dry ice
storage temp.
−20°C
SMILES string
O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCC)=O
InChI key
RJZVWDTYEWCUAR-JOCHJYFZSA-N
Application
15:0 Lyso PC may be used:
- as a reference standard to study the effects of metformin on urinary metabolites in diet-induced-obese mice by ultra-performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF/MS)
- as a standard for the quantification of high-density lipoprotein (HDL) lipidome
- for the preparation of multilamellar vesicles
Packaging
5 mL Amber Glass Screw Cap Vial (855576P-25mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Still not finding the right product?
Explore all of our products under 15:0 Lyso PC
Storage Class
11 - Combustible Solids
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Sterols have higher affinity for sphingomyelin than for phosphatidylcholine bilayers even at equal acyl-chain order
Lonnfors M, et al.
Biophysical Journal, 100(11), 2633-2641 (2011)
Effect of metformin on the urinary metabolites of diet-induced-obese mice studied by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF/MS)
Zhu Y, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 925, 110-116 (2013)
Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein AI deficiency
Zakiev E, et al.
Journal of Clinical Lipidology, 13(3), 468-480 (2019)